Kymera Therapeutics, Inc. (KYMR) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Kymera Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -21.09x | -13.49x | -10.11x | -8.70x | -30.40x | -60.59x |
| P/B Ratio | 4.16x | 3.61x | 3.76x | 2.75x | 6.63x | 9.73x |
| P/S Ratio | 167.51x | 64.14x | 18.91x | 28.75x | 41.83x | 81.17x |
| Profitability | ||||||
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | -891.3% | -555.8% | -210.6% | -344.4% | -138.0% | -136.1% |
| Net Margin | -794.4% | -475.6% | -187.0% | -330.6% | -137.6% | -134.0% |
| EBITDA Margin | -773.1% | -459.4% | -182.2% | -323.9% | -134.1% | -128.4% |
| Liquidity | ||||||
| Current Ratio | 10.47x | 7.53x | 4.73x | 5.88x | 4.88x | 2.73x |
| Quick Ratio | 10.47x | 7.53x | 4.73x | 5.88x | 4.88x | 2.73x |
| Leverage | ||||||
| Debt/Equity | 0.05x | 0.11x | 0.21x | 0.04x | 0.04x | 0.06x |
YoY = year-over-year change. Source: FMP..